**Core Concept**
Chronic administration of certain medications can lead to bone marrow depression, a condition characterized by decreased production of blood cells, including red blood cells, white blood cells, and platelets. This occurs due to the suppression of hematopoiesis, the process of blood cell formation in the bone marrow. The underlying mechanism involves the inhibition of cell division and proliferation in the bone marrow.

**Why the Correct Answer is Right**
The correct answer is a platinum-based chemotherapeutic agent, specifically cisplatin. Cisplatin works by cross-linking DNA, thereby inhibiting DNA replication and transcription. This leads to apoptosis (programmed cell death) of rapidly dividing cells, including cancer cells and bone marrow stem cells. As a result, bone marrow depression occurs, manifesting as pancytopenia (a reduction in all blood cell types).

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it is a non-platinum chemotherapeutic agent. While it may have other side effects, it is not typically associated with bone marrow depression.
* **Option B:** This option is incorrect because it is a non-chemotherapeutic agent. It may have other side effects, but it is not typically associated with bone marrow depression.
* **Option C:** This option is incorrect because it is a non-platinum chemotherapeutic agent. While it may have other side effects, it is not typically associated with bone marrow depression.

**Clinical Pearl / High-Yield Fact**
Platinum-based chemotherapeutic agents, such as cisplatin, can cause cumulative toxicity with repeated administration, leading to prolonged myelosuppression and increased risk of infection and bleeding.

**Correct Answer: C. Cisplatin**